Forex Education Symbols

56 3 (5.66%) 02-16 17:08
Open: 55 Prev Close: 53
High: 58 Low: 55
Volume: 264,631 Market Cap: 45M
Year High: 71.003 Year Low: 9.525
Stock Technical Analysis
Targets Six months: 75.69    One year: 88.40
Supports Support1: 48.24   Support2: 38.00
Resistances Resistance1: 64.80    Resistance2: 75.69 
Pivot Point 55.80 
Moving Averages MA(5): 54.40      MA(20): 56.27 

MA(100): 42.59      MA(250): 31.047 
MACD MACD(12,26): 0.26      Signal(12,26,9): 0.86 
Stochastic Oscillator %K(14,3): 21.16      %D(3): 21.85 
RSI RSI(14): 53.06 
52-Week High: 64.80  Low: 9.52  Change(%): -7.4
Average Volume(K) 3-Month: 28271  10-Days: 9731.759766
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
Bollinger Bands Analysis
AVO.L has closed below upper band by 47.2%. Bollinger Bands are 47.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to AVO.L's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.
Stock News
Advanced Oncotherapy gets boost from stalwart investor
Sun, 10 Dec 2017 15:56:15 GMT

Advanced Oncotherapy PLC (AVO) Increases 5.66% on Feb 17
Sat, 17 Feb 2018 15:56:15 GMT

When Will Advanced Oncotherapy PLC (LON:AVO) Run Out Of Cash?
Thu, 01 Feb 2018 09:11:15 GMT

Elektron Technology shares rise as it sells Queensgate Nano to Prior Scientific
Fri, 16 Feb 2018 09:18:50 GMT

Is It Too Late To Buy Advanced Oncotherapy PLC (AIM:AVO)?
Mon, 04 Sep 2017 14:15:00 GMT

Who Really Owns Advanced Oncotherapy PLC (AIM:AVO)?
Wed, 01 Nov 2017 12:33:45 GMT

Stoxline Canada

Stock Chart London

Option Calculator

EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M)
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
P/E Growth Ratio
P/S 7.60